Intellipharmaceutics International Inc.
IPCIF · OTC
11/30/2022 | 11/30/2021 | 11/30/2020 | 11/30/2019 | |
|---|---|---|---|---|
| Market Cap | $2 | $4 | $3 | $3 |
| - Cash | $0 | $0 | $1 | $0 |
| + Debt | $2 | $2 | $2 | $2 |
| Enterprise Value | $5 | $6 | $4 | $5 |
| Revenue | $0 | $0 | $1 | $1 |
| % Growth | 0% | -95.3% | 0% | – |
| Gross Profit | $0 | -$0 | $1 | $1 |
| % Margin | 100% | -290.2% | 69.3% | 97.6% |
| EBITDA | -$3 | -$3 | -$4 | -$2 |
| % Margin | -4,023.3% | -4,023.3% | -279.1% | -125.8% |
| Net Income | -$3 | -$3 | -$5 | -$3 |
| % Margin | -4,400.6% | -4,400.6% | -367.1% | -241.9% |
| EPS Diluted | -0.087 | -0.098 | -0.22 | -0.16 |
| % Growth | 11.1% | 55.3% | -37.5% | – |
| Operating Cash Flow | -$1 | -$1 | -$2 | $0 |
| Capital Expenditures | $0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$1 | -$1 | -$2 | $0 |